Fulgent Genetics (FLGT) Total Current Liabilities (2015 - 2026)

Fulgent Genetics has disclosed Total Current Liabilities across 12 years of filings, most recently posting $71.8 million for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 0.59% year-over-year to $71.8 million; the TTM figure through Jun 2026 stood at $71.8 million (up 0.59% YoY), while the FY2025 annual figure was $85.0 million, up 16.55% from the prior year.
• Total Current Liabilities came in at $71.8 million for Q2 2026 at Fulgent Genetics, down from $90.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $141.7 million in Q1 2022 to a low of $61.4 million in Q3 2023.
• Average Total Current Liabilities over 5 years is $83.1 million, with a median of $74.9 million recorded in 2024.
• Year-over-year, Total Current Liabilities tumbled 49.17% in 2023 and surged 36.74% in 2026.
• Over 5 years, Total Current Liabilities stood at $88.1 million in 2022, then slipped by 17.13% to $73.0 million in 2023, then dropped by 0.16% to $72.9 million in 2024, then climbed by 16.55% to $85.0 million in 2025, then slipped by 15.55% to $71.8 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $71.8 million in Q2 2026, $90.1 million in Q1 2026, and $85.0 million in Q4 2025.